More news

More news

New Core Lab Enhances Infectious Disease Research at KU

 A new core laboratory at the University of Kansas will enhance the speed, quantity and quality of research into infectious diseases, neurological disorders, cancer and immunology.

Grant Will Fund Research Into Antibiotic Resistance

Joanna Slusky, Associate Professor in the Department of Molecular Biosciences at the University of Kansas, received a four-year grant from the National Institute of General Medical Sciences with a total cost of $1,244,968.

New Grasp of Key COVID-19 Protein May Lead to a Live-Attenuated Vaccine Effective Against More Variants For Longer

Research from the University of Kansas just published in Proceedings of the National Academy of Sciences could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.

Fehr, CBID Faculty Recruit, Published New PNAS Article

Congratulations to Dr. Anthony Fehr, Molecular Biosciences, for his most recent publication.

Fehr, CBID Graduate and Faculty Recruit, Promoted to Associate Professor With Tenure

Congratulations to Dr. Anthony Fehr, Molecular Biosciences, on his promotion to Associate Professor with tenure.  As a CBID faculty recruit and program graduate, we are excited to celebrate your promotion.

Dataset Revolutionizes Understanding Of Beta Barrels, Promising Targets For Vaccine Development

Examples of infections tied to gram-negative bacteria include pneumonia, bloodstream infections, wound-site infections and meningitis, according to the Centers for Disease Control and Prevention.

Slusky, CBID Pilot Project Awardee, Granted $311,242 by NIH

Dr. Joanna Slusky, CBID Pilot Project Awardee, has been granted an R01 award by the National Institutes of Health.  This three year award totals $311,242 and is titled "Plugging & Pulling-in: tuning peptides for ToIC to overcome antibiotic resistance".

Slusky, CBID Pilot Project Leader, has article accepted by PNAS

Dr. Joanna Slusky, Molecular Biosciences, had an article published in PNAS today.

Fehr, CBID Graduate, Granted New Award

Dr. Anthony Fehr, Assistant Professor of Molecular Biosciences, was awarded $50,000 by the University of Kansas Medical Center Research Institute for his project "Investigating Approved Therapeutics For Their Ability To Inhibit the SARS-CoV-2 ADPribosylhydrolase: 2022-2023."

Farrell, CBID Research Project Awardee, Granted $1,912,500 by NIH

Dr. Mark Farrell, Assistant Professor of Medicinal Chemistry, was granted a National Institutes of Health award for $1,912,500.  Titled "Glycoscience Tools and Therapeutics, this five year award is part of the R35 program known as the Outstanding Investigator Award.

Media Contacts

Shelley Sandberg
Program Manager